Kalaris Therapeutics, Inc. Stock Performance
as on April 18, 2026 at 6:59 am IST
Day's Low
Day's High
$6.11$6.68
2.86%
Downside
6.20%
Upside
52 Week's Low
52 Week's High
$2.14$11.8865.98%
Downside
88.87%
Upside
Kalaris Therapeutics, Inc. share price movements today
- Previous Close
- $6.59
- Open
- $6.68
- Volume
- 369.2K
- Day's Low - High
- $6.11 - $6.68
- 52 Week Low - High
- $2.14 - $11.88
Kalaris Therapeutics, Inc. Historical Returns
- 1 Month Return
- -22.65 %
- 3 Month Return
- -32.34 %
- 1 Year Return
- -5.72 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Kalaris Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Kalaris Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$134.6M
EPS (TTM)
-2.255
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-308.10%
Kalaris Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kalaris Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $134.6M | NA | NA | 0.00% | |
| BUY | $42.7B | 130.51% | 136.81 | 8.45% | |
| BUY | $110.8B | 98.57% | 28.42 | 32.94% | |
| NA | $36.8B | NA | 129.84 | 5.37% | |
| BUY | $78.9B | 48.43% | 17.98 | 31.41% |
Stock Returns calculator for Kalaris Therapeutics, Inc. Stock including INR - Dollar returns
The Kalaris Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Kalaris Therapeutics, Inc. investment value today
Current value as on today
₹97,761
Returns
Returns from Kalaris Therapeutics, Inc. Stock
Dollar Impact
₹7,775 (+7.78%)
Kalaris Therapeutics, Inc. Stock’s Investor Sentiment and Interest
Search interest for Kalaris Therapeutics, Inc. Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Kalaris Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Kalaris Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Kalaris Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Kalaris Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Insights on Kalaris Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 44.5%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 114.1%
NEGATIVE IMPACTPrice Dip
In the last 1 month, KLRS stock has moved down by -22.7%
About Kalaris Therapeutics, Inc.
| Organisation | Kalaris Therapeutics, Inc. |
| Headquarters | 400 Connell Drive, Berkeley Heights, NJ, United States, 07922 |
| Industry | Biotechnology |
| CEO | Mr. Andrew Oxtoby |
| E-voting on shares | Click here to vote |
Key Management of Kalaris Therapeutics, Inc.
Name | Title |
|---|---|
Dr. Michael Philip Dybbs Ph.D. | Director & Co-Founder |
Dr. Napoleone Ferrara M.D. | Independent Director & Co-Founder |
Mr. Matthew Gall M.B.A. | CFO & Treasurer |
Mr. Brett R. Hagen | Chief Accounting Officer |
Dr. Matthew Feinsod M.D. | Chief Medical Officer |
Ms. Kristine Curtiss | Senior Vice President of Clinical |
Dr. Jill E. Porter Ph.D. | Senior Vice President of CMC |
Dr. Srinivas Akkaraju M.D., Ph.D. | Director & Co-Founder |
Mr. Andrew Oxtoby | President, CEO & Director |
FAQs
What is Kalaris Therapeutics, Inc. share price today?
Kalaris Therapeutics, Inc. share price today is $6.29 as on at the close of the market. Kalaris Therapeutics, Inc. share today touched a day high of $6.68 and a low of $6.11.
What is the 52 week high and 52 week low for Kalaris Therapeutics, Inc. share?
Kalaris Therapeutics, Inc. share touched a 52 week high of $11.88 on and a 52 week low of $2.14 on . Kalaris Therapeutics, Inc. stock price today i.e. is closed at $6.29,which is 47.05% down from its 52 week high and 193.93% up from its 52 week low.
What is Kalaris Therapeutics, Inc.'s market capitalisation today?
Kalaris Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Kalaris Therapeutics, Inc. Stock (KLRS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kalaris Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kalaris Therapeutics, Inc. Shares that will get you 0.2385 shares as per Kalaris Therapeutics, Inc. share price of $6.29 per share as on April 18, 2026 at 1:29 am IST.
What is the minimum amount required to buy Kalaris Therapeutics, Inc. Stock (KLRS) from India?
Indian investors can start investing in Kalaris Therapeutics, Inc. (KLRS) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Kalaris Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kalaris Therapeutics, Inc. share’s latest price of $6.29 as on April 18, 2026 at 1:29 am IST, you will get 1.5898 shares of Kalaris Therapeutics, Inc.. Learn more about
fractional shares .